Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
Shenyang Xingqi Pharmaceutical (300573 CH)
Watchlist
36
Analysis
Health Care
•
China
Shenyang Xingqi Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, produces, and distributes ophthalmic medicines including anti-bacterial products, allergy medicines, cataract preventions, and glaucoma treatments.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Bluefocus Communication Group Co, Ltd.
•
03 Jun 2025 11:05
ChiNext/ChiNext 50 Index Rebalance: US$1.3bn Round-Trip Trade
There are 8 changes for the ChiNext Index and 5 changes for the ChiNext 50 Index at the June rebalance. The round-trip trade across both indices is...
Brian Freitas
Follow
650 Views
Share
bullish
•
All Winner Technology
•
15 May 2025 06:30
ChiNext/ChiNext50 Index Rebalance Preview: Whole Lotta Change
There could be 10/5 changes for the Chinext/50 in June with 10 stocks having over 1x ADV to trade from passives. Adds have outperformed the deletes...
Brian Freitas
Follow
547 Views
Share
bearish
•
Sonoscape Medical Corp
•
17 Apr 2025 17:50
Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Some New Expectations; Try Sector-Neutral Pairs
There could be roughly US$1.4bn in total one-way flows for ChiNext and ChiNext 50 during the June 2025 index rebalance event. Some expectations...
Janaghan Jeyakumar, CFA
Follow
744 Views
Share
bullish
•
Shandong Weifang Rainbow Chemi
•
20 Mar 2025 14:04
Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: US$1.4bn Total One-Way Flows; Basket Trade Idea
There could be ~US$1.1bn and ~US$300mn one-way flows for ChiNext and ChiNext 50 respectively. There is one change in the expected ADDs/DELs for...
Janaghan Jeyakumar, CFA
Follow
416 Views
Share
bearish
•
Cloudbreak Pharma
•
06 Feb 2025 08:32
Cloudbreak 拨康视云 IPO: Negative Readthrough from Underperforming Market Leader
Cloudbreak re-files for Hong Kong listing to raise $100M, core product progress on track but delays in other products, negative readthrough from...
Ke Yan, CFA, FRM
Follow
606 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x